Barely a week into his second term, Trump has issued several executive actions that are reshaping DEI programs across the federal government and corporate America. Since his inauguration on January 20,

The Boston university's webpage formerly titled, "The Office of Diversity, Equity and Inclusion," is now "Belonging in Northeastern."

The Food & Drug Administration (FDA), has quietly taken down their guidance detailing diversity action plans for clinical trials. Could this cut to DEI cost lives?